
Sermorelin
Sermorelin (GRF 1-29 NH2)
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of human growth hormone-releasing hormone (GHRH), with an amidated C-terminus. Structure–activity studies in the 1980s established that this N-terminal 1-29 fragment is the shortest sequence retaining the full biological activity of the 44-residue native hormone, which made it one of the earliest GHRH analogs studied.
In laboratory research, sermorelin is used to stimulate the GHRH receptor directly and examine pituitary growth hormone release under physiological feedback control. It also serves as the parent sequence for later modified analogs such as Modified GRF (1-29), better known as CJC-1295 without DAC, which adds substitutions to resist enzymatic breakdown.
PhysIQ Peptides supplies sermorelin as a lyophilized powder, third-party tested for purity and identity, for in vitro and laboratory research use only.
Choose how to buy
You save $1.75 every reship · ≈ $21.29 saved per year
Auto-delivered • Skip or cancel anytime • Never run out
Your first order ships at the regular price. Every reship after that is 5% off. Pause, change the interval, or cancel anytime.
- Purity
- 99%
- Form
- Powder (lyophilized)
- CAS Number
- 86168-78-7
- Molecular Formula
- C149H246N44O42S
- Molecular Weight
- 3357.9 g/mol
- Available sizes
- 5mg
Sequence
YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2
Mechanism of Action
Sermorelin is an agonist of the GHRH receptor on anterior pituitary somatotrophs. Binding activates Gs and adenylyl cyclase, raising cAMP and stimulating both growth hormone gene transcription and pulsatile GH release. Its short half-life, due to rapid DPP-4 cleavage, makes it useful for studying acute GHRH receptor stimulation in research models.
Research Areas
- ●GHRH receptor pharmacology
- ●Pituitary growth hormone release models
- ●Structure–activity studies of GHRH fragments
- ●GH / IGF-1 axis research




